← Evidence map

ArticleCancers2025

A Novel Protein Serum Biomarker Assay for Tracking (Neo)adjuvant and Metastatic Therapy Efficacy and Enabling the Timely Detection of Relapse in Breast Cancer.

Jeffrey Dea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41463256